PARI GmbH
http://www.pari.de/de-en/home/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From PARI GmbH
Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.
Breath Therapeutics Snapped Up Post Series A By Specialty Company Zambon
Italy’s privately held Zambon could pay up to €500m to bulk up its respiratory products pipeline, producing a nice return for Breath Therapeutics’ syndicate of European investors.
Germany Marketing Round Up December 2018: New OTC Products For The Winter Cough and Cold Season
Five new OTC cough and cold products have hit the shelves in Germany this winter from Pari, Pohl Boskamp, Engelhard Arzneimittel, GSK and Dr Soldan.
Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA
The latest drug development news and highlights from our FDA Performance Tracker.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
-
Drug Delivery
- Pulmonary
- Site Specific
- Other Names / Subsidiaries
-
- PARI Medical Holding
- PARI Pharma GmbH
- PARltec GmbH
- PARI Worldwide, PARI Respiratory Equipment, Inc.